Shopping Cart
Remove All
Your shopping cart is currently empty
A2AAR antagonist 3 is a potent and selective A2A adenosine receptor (A2AAR) antagonist with an IC50 value of 1.57 nM. It exhibits a high binding affinity specifically for A2AAR. In vitro studies demonstrate its good stability in rat liver microsomes, and it possesses acceptable pharmacokinetic properties in vivo. A2AAR antagonist 3 is applicable for cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | A2AAR antagonist 3 is a potent and selective A2A adenosine receptor (A2AAR) antagonist with an IC50 value of 1.57 nM. It exhibits a high binding affinity specifically for A2AAR. In vitro studies demonstrate its good stability in rat liver microsomes, and it possesses acceptable pharmacokinetic properties in vivo. A2AAR antagonist 3 is applicable for cancer research. |
| In vitro | A2AAR antagonist 3 (Compound 12a) at a concentration of 1 μM over 48 hours can restore IL-2 secretion in human peripheral blood mononuclear cells inhibited by NECA (1 μM, pretreated for 30 minutes). Furthermore, A2AAR antagonist 3, within a range of 3.125-100 μM over 24 hours, shows no significant toxicity to L929, H9C2, and HTX2426 cells. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.